3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Multiple Myeloma
4
Barrett Esophagus
3
Venous Thromboembolism
2
Tobacco Use Disorder
2
Prostatic Neoplasms
2
Precancerous Conditions
2
Polycythemia Vera
2
Myocardial Infarction
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Vascular Diseases
1
Triple Negative Breast Neoplasms
1
Thromboembolism
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Stroke
1
Soft Tissue Neoplasms
1
Smoking Cessation
1
Sarcoma
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Node Positive HER2 Negative Breast Cancer
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Myeloproliferative Disorders
1
Multiple Pulmonary Nodules
1
Interventions
Gemcitabine
47
Cisplatin
32
pembrolizumab
28
Paclitaxel
13
Docetaxel
13
avelumab
12
Mitomycin
12
atezolizumab
11
Nivolumab
11
Cystectomy
10
Carboplatin
9
durvalumab
7
Sunitinib
7
apaziquone
6
Doxorubicin
6
BCG Vaccine
6
5-aminolevulinic acid hexyl ester
6
Vinblastine
5
Radiation
5
Platinum
5
Methotrexate
5
Magnetic Resonance Spectroscopy
5
Albumin-Bound Paclitaxel
5
Taxes
4
Standard of Care
4
Sorafenib
4
Radiotherapy
4
Fluorouracil
4
Erlotinib Hydrochloride
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urinary Bladder Neoplasms
×
Aspirin
×
Clear all
No trials found.